Posted On: 01/28/2014 12:15:37 PM
Post# of 102755
$SRPT Up to date company activities and other important information about $SRPT
$SRPT
DD Notes ~ http://www.ddnotesmaker.com/SRPT
##### recent news/filings ~ source: finance.yahoo.com
Mon, 27 Jan 2014 23:19:12 GMT ~ INVESTOR ALERT: Federman & Sherwood Files First Securities Class Action Lawsuit Against Sarepta Therapeutics, Inc.
- Federman & Sherwood, a law firm with extensive experience representing investors in securities, derivative and merger-related shareholder class actions, announces the filing of the first securities class ...
read full: http://finance.yahoo.com/news/investor-alert-...12195.html
*********************************************************
Mon, 27 Jan 2014 11:24:52 GMT ~ Sarepta downgraded to Market Perform from Outperform at JMP Securities
- JMP Securities downgraded Sarepta due to valuation and expectations pivotal data and approval of its Duchenne Muscular Dystrophy drug will take longer than expected.
read full: http://finance.yahoo.com/news/sarepta-downgra...52061.html
*********************************************************
Fri, 24 Jan 2014 16:28:38 GMT ~ EU panel recommends against PTC Therapeutics drug
- PTC Therapeutics Inc (NasdaqGS: PTCT - news) said its drug to treat a rare muscular disorder failed to win support for a conditional approval from a panel of the European Medicines Agency, sending its shares down as much as 17 percent in morning trading. It also said the drug showed limited evidence of having beneficial effects on the daily activities of patients with a form of Duchenne muscular dystrophy (DMD), a genetic disorder that causes muscle degeneration and eventual death in boys. Analysts said conditional approval for the drug had been considered unlikely, and remained positive on its potential for eventual approval by the EMA. A conditional approval is granted to treatments that address unmet medical needs.
read full: http://uk.finance.yahoo.com/news/eu-panel-rec...58151.html
*********************************************************
Fri, 24 Jan 2014 05:18:15 GMT ~ Intercept Pharmaceticals & Chelsea Therapeutics: Which is Best?
- Intercept Pharmaceuticals and Chelsea Therapeutics both rallied with remarkable gains, but do both stocks still have further upside, or can we expect volatile Sarepta Therapeutics-like years ahead?
read full: http://www.fool.com/investing/general/2014/01...lnk0000001
*********************************************************
Thu, 23 Jan 2014 12:25:23 GMT ~ The Zacks Analyst Blog Highlights: Celgene, Jazz, Sarepta, Alnylam and Regeneron
- The Zacks Analyst Blog Highlights: Celgene, Jazz, Sarepta, Alnylam and Regeneron
read full: http://finance.yahoo.com/news/zacks-analyst-b...23061.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=SRPT&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=SRPT&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SRPT/company-info
Ticker: $SRPT
OTC Market Place: Not Available
CIK code: 0000873303
Company name: Sarepta Therapeutics, Inc.
Company website: http://www.antivirals.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/SRPT/filings
Latest financials: http://www.otcmarkets.com/stock/SRPT/financials
Latest news: http://www.otcmarkets.com/stock/SRPT/news - http://finance.yahoo.com/q/h?s=SRPT+Headlines
Major holdings: http://data.cnbc.com/quotes/SRPT/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SRPT+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SRPT.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SRPT
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Sarepta+Therapeuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.antivirals.com
Alexa: http://www.alexa.com/siteinfo/http://www.antivirals.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.antivirals.com
http://www.pennystocktweets.com/stocks/profile/SRPT
##### last known share structure ~ source: otcmarkets.com
Market Value: $1,559,290,000 a/o Jan 27, 2014
Shares Outstanding: 37,582,309 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/SRPT
$SRPT
DD Notes ~ http://www.ddnotesmaker.com/SRPT
##### recent news/filings ~ source: finance.yahoo.com
Mon, 27 Jan 2014 23:19:12 GMT ~ INVESTOR ALERT: Federman & Sherwood Files First Securities Class Action Lawsuit Against Sarepta Therapeutics, Inc.
- Federman & Sherwood, a law firm with extensive experience representing investors in securities, derivative and merger-related shareholder class actions, announces the filing of the first securities class ...
read full: http://finance.yahoo.com/news/investor-alert-...12195.html
*********************************************************
Mon, 27 Jan 2014 11:24:52 GMT ~ Sarepta downgraded to Market Perform from Outperform at JMP Securities
- JMP Securities downgraded Sarepta due to valuation and expectations pivotal data and approval of its Duchenne Muscular Dystrophy drug will take longer than expected.
read full: http://finance.yahoo.com/news/sarepta-downgra...52061.html
*********************************************************
Fri, 24 Jan 2014 16:28:38 GMT ~ EU panel recommends against PTC Therapeutics drug
- PTC Therapeutics Inc (NasdaqGS: PTCT - news) said its drug to treat a rare muscular disorder failed to win support for a conditional approval from a panel of the European Medicines Agency, sending its shares down as much as 17 percent in morning trading. It also said the drug showed limited evidence of having beneficial effects on the daily activities of patients with a form of Duchenne muscular dystrophy (DMD), a genetic disorder that causes muscle degeneration and eventual death in boys. Analysts said conditional approval for the drug had been considered unlikely, and remained positive on its potential for eventual approval by the EMA. A conditional approval is granted to treatments that address unmet medical needs.
read full: http://uk.finance.yahoo.com/news/eu-panel-rec...58151.html
*********************************************************
Fri, 24 Jan 2014 05:18:15 GMT ~ Intercept Pharmaceticals & Chelsea Therapeutics: Which is Best?
- Intercept Pharmaceuticals and Chelsea Therapeutics both rallied with remarkable gains, but do both stocks still have further upside, or can we expect volatile Sarepta Therapeutics-like years ahead?
read full: http://www.fool.com/investing/general/2014/01...lnk0000001
*********************************************************
Thu, 23 Jan 2014 12:25:23 GMT ~ The Zacks Analyst Blog Highlights: Celgene, Jazz, Sarepta, Alnylam and Regeneron
- The Zacks Analyst Blog Highlights: Celgene, Jazz, Sarepta, Alnylam and Regeneron
read full: http://finance.yahoo.com/news/zacks-analyst-b...23061.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=SRPT&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=SRPT&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SRPT/company-info
Ticker: $SRPT
OTC Market Place: Not Available
CIK code: 0000873303
Company name: Sarepta Therapeutics, Inc.
Company website: http://www.antivirals.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/SRPT/filings
Latest financials: http://www.otcmarkets.com/stock/SRPT/financials
Latest news: http://www.otcmarkets.com/stock/SRPT/news - http://finance.yahoo.com/q/h?s=SRPT+Headlines
Major holdings: http://data.cnbc.com/quotes/SRPT/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SRPT+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SRPT.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SRPT
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Sarepta+Therapeuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.antivirals.com
Alexa: http://www.alexa.com/siteinfo/http://www.antivirals.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.antivirals.com
http://www.pennystocktweets.com/stocks/profile/SRPT
##### last known share structure ~ source: otcmarkets.com
Market Value: $1,559,290,000 a/o Jan 27, 2014
Shares Outstanding: 37,582,309 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/SRPT
(0)
(0)
